Loading...
Huntsman Corp (HUN) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The stock's technical indicators are weak, financial performance is declining, and there are no strong positive catalysts to offset these concerns. A hold is recommended until clearer signs of recovery or positive momentum emerge.
The MACD is negative and expanding (-0.187), indicating bearish momentum. RSI is at 36.229, suggesting the stock is approaching oversold territory but not yet signaling a reversal. The stock is trading near its support level (S1: 11.816), with resistance levels far above (R1: 13.97). Moving averages are converging, showing no clear trend.

Insiders are buying, with a 106.11% increase in buying activity over the last month. Some analysts have raised price targets, indicating potential for recovery in the long term.
The company's Q4 financials show significant declines in revenue (-6.68% YoY), net income (-31.91% YoY), and EPS (-31.71% YoY). Gross margin also dropped to 12.1%. Analyst ratings are mixed, with several firms maintaining Neutral or Sell ratings. Technical indicators suggest bearish momentum, and options data reflects negative sentiment.
In Q4 2025, Huntsman reported a revenue decline to $1.355 billion (-6.68% YoY), a net income loss of $96 million (-31.91% YoY), and an EPS drop to -0.56 (-31.71% YoY). Gross margin fell to 12.1% (-6.56% YoY), indicating deteriorating profitability.
Analyst ratings are mixed, with price targets ranging from $9 to $55. While some analysts raised targets following the Q4 earnings report, others downgraded the stock due to valuation concerns and weak demand in the chemical sector. JPMorgan downgraded the stock to Neutral, citing that the stock already prices in a cyclical recovery.